HIV-related TB Treatment Intermittency in the Continuation Phase and Mortality
The 2016 ATS/CDC/IDSA tuberculosis (TB) treatment guidelines recommend daily TB treatment in both the intensive and continuation phases of treatment in HIV-infected persons to decrease the risk of relapse and acquired drug resistance. However, guidelines vary across regions and countries, and treatment is given 7, 5, 3, or 2 days/week. The effect of TB treatment…